EP-51216
EP-51216 is a growth hormone agonist peptide. EP-51216 increases food intake. EP-51216 can be used in the research of eating disorders.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 219517-98-3
- Fòrmula: C46H58N10O5
- Peso molecular:831.02
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Descripciòn
Chemical Information
-
No. CAS 219517-98-3
-
Peso molecular 831.02
-
Fòrmula C46H58N10O5
-
SMILES
NCCCC[C@@H](C(N)=O)NC([C@H](CC1=C(C)NC2=CC=CC=C12)NC([C@@H](CC3=C(C)NC4=CC=CC=C34)NC([C@@H](CC5=C(C)NC6=CC=CC=C56)NC(CCCN)=O)=O)=O)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocolo
-
Research Protocol for Endocrine Diseases
Endocrine diseases often arise from disrupted hormone production, hormone signaling, or target-tissue responsiveness; for diabetes-focused endocrine disease models, insulin signaling regulates glucose uptake, hepatic glucose output, lipid metabolism, and β-cell compensation. Type 2 diabetes develops through interacting defects in insulin resistance, β-cell dysfunction, adipose inflammation, hepatic glucose overproduction, altered incretin signaling, and ectopic lipid metabolism. A major unresolved question is whether endocrine dysfunction is driven primarily by target-tissue insulin resistance, intrinsic β-cell failure, immune/inflammatory stress, or combined multi-organ failure that differs by disease stage.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)